Cargando…
Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts
There are nearly 65 million people with chronic heart failure (CHF) globally, with no treatment directed at the pathologic cause of the disease, the loss of functioning cardiomyocytes. We have an allogeneic cardiac patch comprised of cardiomyocytes and human fibroblasts on a bioresorbable matrix. Th...
Autores principales: | Lancaster, J. J., Grijalva, A., Fink, J., Ref, J., Daugherty, S., Whitman, S., Fox, K., Gorman, G., Lancaster, L. D., Avery, R., Acharya, T., McArthur, A., Strom, J., Pierce, M. K., Moukabary, T., Borgstrom, M., Benson, D., Mangiola, M., Pandey, A. C., Zile, M. R., Bradshaw, A., Koevary, J. W., Goldman, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676365/ https://www.ncbi.nlm.nih.gov/pubmed/38007534 http://dx.doi.org/10.1038/s42003-023-05564-w |
Ejemplares similares
-
Epicardially Placed Bioengineered Cardiomyocyte Xenograft in Immune-Competent Rat Model of Heart Failure
por: Chinyere, Ikeotunye Royal, et al.
Publicado: (2021) -
Free-breathing gradient recalled echo-based CMR in a swine heart failure model
por: Morris, Craig C., et al.
Publicado: (2022) -
Surgical treatment for heart failure: cell-based therapy with engineered tissue
por: Lancaster, Jordan J., et al.
Publicado: (2019) -
Second-generation extracellular matrix patch for epicardial infarct repair
por: Bhatt, Arjun, et al.
Publicado: (2023) -
A randomised controlled trial is not a pilot trial simply because it uses a surrogate endpoint
por: Campbell, M. J., et al.
Publicado: (2018)